Skip to main content
Home
  • About
    • About SGC
    • Members & Technology Partners
    • Governance
    • Open Science
    • Impact
    • SGC Gender Equality Plan
  • SGC Sites & People
    • Global
    • SGC Toronto
    • SGC UNC
    • SGC Karolinska
    • SGC Frankfurt
    • SGC Neuro
    • SGC UCL
    • SGC Unicamp
  • Science and Resources
    • Proteins
      • Structure Gallery
      • Protein Production Resources
        • Expression Vectors
        • Constructs
        • Legacy Protein Protocols
    • Chemistry
      • Chemical Probes
        • SGC Chemical Probes
        • Donated Chemical Probes
        • Chemical Handles
      • Chemogenomic Sets
    • Open Data
    • Target Enabling Packages
    • Patient Tissue Platform
    • Open Lab Notebooks
    • Publications
    • Bioinformatics Resources
      • ChemBioPort
      • UbiHub
      • ChromoHub
  • Initiatives
    • Overview
      • Target 2035
      • Protein Contribution Network
      • AIRCHECK
      • MAINFRAME
      • CACHE
      • Conscience
      • Agora Open Science Trust
      • EUbOPEN
      • Open Chemistry Networks
      • Women’s and Children’s Health Initiative
      • READDI AViDD
      • TREAT AD
      • YCharOS
  • News & Outreach
    • News from SGC
    • Press Releases
    • Blogs
  • Get Involved
    • Participate
    • Donate
    • Careers
    • Contact Us
  • Home
  • About
    • About SGC
    • Members & Technology Partners
    • Governance
    • Open Science
    • Impact
    • SGC Gender Equality Plan
  • SGC Sites & People
    • Global
    • SGC Toronto
    • SGC UNC
    • SGC Karolinska
    • SGC Frankfurt
    • SGC Neuro
    • SGC UCL
    • SGC Unicamp
  • Science and Resources
    • Proteins
      • Structure Gallery
      • Protein Production Resources
        • Expression Vectors
        • Constructs
        • Legacy Protein Protocols
    • Chemistry
      • Chemical Probes
        • SGC Chemical Probes
        • Donated Chemical Probes
        • Chemical Handles
      • Chemogenomic Sets
    • Open Data
    • Target Enabling Packages
    • Patient Tissue Platform
    • Open Lab Notebooks
    • Publications
    • Bioinformatics Resources
      • ChemBioPort
      • UbiHub
      • ChromoHub
  • Initiatives
    • Overview
      • Target 2035
      • Protein Contribution Network
      • AIRCHECK
      • MAINFRAME
      • CACHE
      • Conscience
      • Agora Open Science Trust
      • EUbOPEN
      • Open Chemistry Networks
      • Women’s and Children’s Health Initiative
      • READDI AViDD
      • TREAT AD
      • YCharOS
  • News & Outreach
    • News from SGC
    • Press Releases
    • Blogs
  • Get Involved
    • Participate
    • Donate
    • Careers
    • Contact Us

Biochemical investigation of LC3/GABARAP-ligand interaction as an important quality measure for LC3/GABARAP-targeting small molecules: addendum to the guidelines (4th edition).

  • Read more about Biochemical investigation of LC3/GABARAP-ligand interaction as an important quality measure for LC3/GABARAP-targeting small molecules: addendum to the guidelines (4th edition).

Structural basis of TMPRSS11D specificity and autocleavage activation.

  • Read more about Structural basis of TMPRSS11D specificity and autocleavage activation.

Species-Dependent Metabolism of a Covalent nsP2 Protease Inhibitor with In Vivo Antialphaviral Activity.

  • Read more about Species-Dependent Metabolism of a Covalent nsP2 Protease Inhibitor with In Vivo Antialphaviral Activity.

PRMT1 inhibitor MS023 suppresses RNA splicing to sensitize small cell lung cancer to DNA damaging agents.

  • Read more about PRMT1 inhibitor MS023 suppresses RNA splicing to sensitize small cell lung cancer to DNA damaging agents.

Active Learning-Guided Hit Optimization for the Leucine-Rich Repeat Kinase 2 WDR Domain Based on In Silico Ligand-Binding Affinities.

  • Read more about Active Learning-Guided Hit Optimization for the Leucine-Rich Repeat Kinase 2 WDR Domain Based on In Silico Ligand-Binding Affinities.

Type II kinase inhibitors that target Parkinson's disease-associated LRRK2.

  • Read more about Type II kinase inhibitors that target Parkinson's disease-associated LRRK2.

THNAN69

  • Read more about THNAN69

SM311

  • Read more about SM311

BI-5121

  • Read more about BI-5121

BAY-439

  • Read more about BAY-439

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

A global public-private partnership that supports the discovery of new medicines through open-access research.

  • Careers
  • Contact Us

Structural Genomics Consortium. Registered charity 1097737 (England and Wales). Registered company limited by guarantee 04714553 (England and Wales). Except where otherwise noted, all content on this site is licensed under a Creative Commons Attribution 4.0 International license (CC BY 4.0)

Be the first to know with our SGC Bulletin!

Want to know what we are up to?
Leave your e-mail address below and you will receive a monthly source of SGC news from across our six research sites.

SIGN UP FOR OUR NEWSLETTER

Footer

  • Privacy Policy
  • Legal Information
  • Contact Us
  • Login